US4394445A - Enzymatic glyceride hydrolysis - Google Patents

Enzymatic glyceride hydrolysis Download PDF

Info

Publication number
US4394445A
US4394445A US06/331,449 US33144981A US4394445A US 4394445 A US4394445 A US 4394445A US 33144981 A US33144981 A US 33144981A US 4394445 A US4394445 A US 4394445A
Authority
US
United States
Prior art keywords
glycerol
lipase
units
serum
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US06/331,449
Inventor
Paul T. Nix
Janet M. Santoro
Joyce E. Stephens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COOPERBIOMEDICAL Inc 3145 PORTER DRIVE PALO ALTO CA 94304 A CORP OF
Original Assignee
Nix Paul T
Santoro Janet M
Stephens Joyce E
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nix Paul T, Santoro Janet M, Stephens Joyce E filed Critical Nix Paul T
Priority to US06/331,449 priority Critical patent/US4394445A/en
Application granted granted Critical
Publication of US4394445A publication Critical patent/US4394445A/en
Assigned to COOPERBIOMEDICAL, INC., 3145 PORTER DRIVE, PALO ALTO CA. 94304 A CORP OF DE reassignment COOPERBIOMEDICAL, INC., 3145 PORTER DRIVE, PALO ALTO CA. 94304 A CORP OF DE ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: FLOW GENERAL INC., A DE CORP
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00Production of fats or fatty oils from raw materials
    • C11B1/02Pretreatment
    • C11B1/04Pretreatment of vegetable raw material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18Carboxylic ester hydrolases (3.1.1)
    • C12N9/20Triglyceride splitting, e.g. by means of lipase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/38Pseudomonas
    • C12R2001/39Pseudomonas fluorescens
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • C12R2001/845Rhizopus

Definitions

  • This invention relates to the in vitro clinical determination of glycerol esters in body fluids, and more particularly to the hydrolysis of glycerides to glycerol for analysis.
  • Glyceride concentration particularly triglycerides in the body fluids of man and other animals, are known to be significant to a number of pathological conditions and its determination is a common clinical procedure.
  • the glycerides are hydrolyzed and the glycerol thus freed is assayed by a variety of techniques. Hydrolysis by both chemical and enzymatic means are known, with the latter being generally preferred for safety, specificity and convenience.
  • a number of single source lipases have been proposed, for example, Rhizopus arrhizus lipase (hereinafter LIPR) in U.S. Pat. No.
  • the glycerol freed may be assayed by any suitable procedure.
  • the glycerol kinase procedure is commonly used and is described in a number of publications, including U.S. Pat. Nos. 3,703,591; 3,759,793; and 4,056,442 and the Technicon Instruments Corporation publication dated March, 1976, entitled "Technicon Method No. SG4-0023PC6. These disclosures are herein incorporated by reference.
  • Methods which measure the reduction of NAD by other enzymatic means are also known and are described for example in U.S. Pat. No. 4,056,442 and in Clinica Chimica Acta, 81 (1977) 125:130. These disclosures are also incorporated herein by reference.
  • a novel mixture of lipases has been found which are stable and which will fully hydrolyze trigercides in body fluids in the short times available in continuous flow analyzers and in the presence of surfactants.
  • This mixture is useable in manual or other procedures, but is especially adapted for rapid, continuous flow instrumental assay.
  • any suitable procedure is employed to assay the released glycerol, for example, the glycerol kinase, NADH/NAD procedure described above.
  • the novel mixture comprises a mixture of Rhizopus arrhizus lipase (LIPR) and Pseudomonas fluorescens lipase (LPL) in the ratio of units/milliliter of each lipase between about 2:1 and about 10:1, more preferably between about 4:1 and 10:1, and most preferably about 5:1.
  • LIPR Rhizopus arrhizus lipase
  • LPL Pseudomonas fluorescens lipase
  • the mixture per hundred units of total lipase, should comprise between about 65 and 91 units LIPR and 35 to 9 units LPL.
  • Sufficient total lipase to hydrolyze the sample within the available time should be employed. For rapidly hydrolyzing about 20 microliters of test sample containing up to 5 grams per liter or more of triglyceride, about 150 units of total lipase should be employed.
  • a mixture of 250 u/ml Rhizopus arrhizus lipase and 50 u/ml Pseudomonas fluorescens lipase is preferred.
  • the mixture should be buffered to a pH between about 6.0 and 7.0, more preferably 6.4 to 6.5, and is preferably lyophilized for stability or prepared as a dry powder.
  • Rhizopus arrhizus lipase (E.C. 3.1.1.3) is described in the foregoing publications and one method for its preparation is disclosed in U.S. Pat. No. 3,513,073. Pseudomonas fluorescens lipase and methods for its preparation are disclosed in U.S. Pat. No. 3,431,175 and in Clinica Chimica Acta, 81 (1977) 125:130. Both are commercially available and the organisms are on deposit in recognized collections.
  • a unit of lipase activity as used herein is the amount of fatty acid neutralized by one micromole of sodium hydroxide in one minute at 25° C. at pH 8.
  • the preferred hydrolyzing lipase mixture according to the present invention is an aqueous solution shown in Example 1 below. It is preferably supplied in dry or dried form for stability in storage and is reconstituted with distilled water prior to use.
  • a serum sample is diluted 1:6 by volume with distilled water containing a small quantity of surfactant, e.g., 0.1% Triton X-100 (DuPont), and 4.25 parts by volume of the reconstituted lipase reagent is added to each part of diluted sample.
  • a small quantity of surfactant e.g. 0.1% Triton X-100 (DuPont)
  • 4.25 parts by volume of the reconstituted lipase reagent is added to each part of diluted sample.
  • 118 ul of diluted sample is used in the above identified instrument and about 0.4 ml of lipase reagent added per test. Complete hydrolysis is obtained in 2.5 minutes.
  • Samples 1-8 are patient sera where triglyceride concentrations were measured after effecting hydrolysis using the preferred lipase formulation of Example 1 on a Technicon SMAC instrument, and where the Expected Value of each serum was determined using a commercial lipase reagent based on U.S. Pat. No. 3,703,951. Correlation of these sera show that the surfactants used in the instrument calibration did not inhibit the lipase reaction.
  • glycerol freed by hydrolysis was dialyzed into a flowing stream of assay reagent using the NADH to NAD reactions described above, the resulting change in absorbance being read optically at 340 nm and calibrated to triglyceride concentration in sample.
  • a preferred free glycerol reagent mixture is given in Example 2 below, the amounts given being per aqueous liter.

Abstract

A new stable combination of Rhizopus arrhizus lipase and Pseudomonas fluorescens lipase for hydrolyzing triglycerides to free glycerol in body fluids is disclosed. Substantially complete and rapid hydrolysis is provided by a mixture of enzymes using a ratio between 2:1 and 10:1, about 5:1 being preferred, the amounts representing units of activity of each lipase. Approximately 150 units of total lipases will provide substantially complete hydrolysis of the triglycerides contained in 20 microliters of serum up to a minimum concentration of 5 g./l. within 2.5 minutes at 37° C.

Description

This application is a continuation of application Ser. No. 187,664 filed Sept. 16, 1980, abandoned, and a continuation of application Ser. No. 013,862 filed Feb. 22, 1979, abandoned.
BACKGROUND OF THE INVENTION
This invention relates to the in vitro clinical determination of glycerol esters in body fluids, and more particularly to the hydrolysis of glycerides to glycerol for analysis.
Glyceride concentration, particularly triglycerides in the body fluids of man and other animals, are known to be significant to a number of pathological conditions and its determination is a common clinical procedure. Generally, the glycerides are hydrolyzed and the glycerol thus freed is assayed by a variety of techniques. Hydrolysis by both chemical and enzymatic means are known, with the latter being generally preferred for safety, specificity and convenience. A number of single source lipases have been proposed, for example, Rhizopus arrhizus lipase (hereinafter LIPR) in U.S. Pat. No. 3,759,793, and Pseudomonas fluorescens lipase (hereinafter LPL) in Chimica Chimica Acta, 81 (1977) 125:130. However, such single source lipases either will not fully hydrolyze glycerides or will do so only under limited conditions or with impractically large amounts of enzyme or time. Thus, so far as known, such single source lipases are not used. Instead, mixtures of enzymes are employed, for example, LIPR with protease as disclosed in U.S. Pat. No. 3,708,591; mixtures of LIPR and carboxylesterase as disclosed in U.S. Pat. No. 3,862,009; and mixtures of LIPR with Candida cylindracea as disclosed in U.S. Pat. No. 4,056,442. Such mixtures also have limitations, however. Proteases limit stability of the reagent since they eventually attack protein in the reagent or sample, carboxyleasterases are difficult to purify, and combinations of LIPR and Candida cyclindracea lipases are inhibited by wetting agents commonly used in reagents, samples or controls, especially in automated, continuous flow analyzers.
Automated continuous flow analyzers impose important limitations on conditions for hydrolyzing triglycerides. Frequently calibrators and standards contain surfactants, while use of small samples and short reaction times are common. For example, the Technicon SMAC instrument provides a fixed incubation time of 2.5 minutes at 37° C., and employs surfactants in its calibrating standards which inhibit some lipases, for example the mixture disclosed in U.S. Pat. No. 4,056,442.
Following hydrolysis of triglyercides, the glycerol freed may be assayed by any suitable procedure. The glycerol kinase procedure is commonly used and is described in a number of publications, including U.S. Pat. Nos. 3,703,591; 3,759,793; and 4,056,442 and the Technicon Instruments Corporation publication dated March, 1976, entitled "Technicon Method No. SG4-0023PC6. These disclosures are herein incorporated by reference.
In one procedure, the assay reactions are summarized as follows: ##STR1## As used above, FFA=free fatty acids; ATP=adenosine triphosphate; GK=glycerol kinase; GP=glycerol phosphate; ADP--adenosine diphosphate; PEP=phosphoenolpyruvic acid; LDH=lactate dehydrogenase; PK=pyruvate kinase; NAD and NADH=Nicotinamide adenine dinucleotide, oxidized and reduced. NADH absorbs at 340 nm while NAD does not, the decrease in optical absorbance at 340 nm being measured and calibrated as a measure of the concentration of triglycerides in the sample. Methods which measure the reduction of NAD by other enzymatic means are also known and are described for example in U.S. Pat. No. 4,056,442 and in Clinica Chimica Acta, 81 (1977) 125:130. These disclosures are also incorporated herein by reference.
SUMMARY OF THE INVENTION
According to the present invention, a novel mixture of lipases has been found which are stable and which will fully hydrolyze trigercides in body fluids in the short times available in continuous flow analyzers and in the presence of surfactants. This mixture is useable in manual or other procedures, but is especially adapted for rapid, continuous flow instrumental assay. Following hydrolysis therewith, any suitable procedure is employed to assay the released glycerol, for example, the glycerol kinase, NADH/NAD procedure described above.
The novel mixture comprises a mixture of Rhizopus arrhizus lipase (LIPR) and Pseudomonas fluorescens lipase (LPL) in the ratio of units/milliliter of each lipase between about 2:1 and about 10:1, more preferably between about 4:1 and 10:1, and most preferably about 5:1. Thus the mixture, per hundred units of total lipase, should comprise between about 65 and 91 units LIPR and 35 to 9 units LPL. Sufficient total lipase to hydrolyze the sample within the available time should be employed. For rapidly hydrolyzing about 20 microliters of test sample containing up to 5 grams per liter or more of triglyceride, about 150 units of total lipase should be employed. A mixture of 250 u/ml Rhizopus arrhizus lipase and 50 u/ml Pseudomonas fluorescens lipase is preferred. The mixture should be buffered to a pH between about 6.0 and 7.0, more preferably 6.4 to 6.5, and is preferably lyophilized for stability or prepared as a dry powder.
DETAILED DESCRIPTION OF THE INVENTION
Rhizopus arrhizus lipase (E.C. 3.1.1.3) is described in the foregoing publications and one method for its preparation is disclosed in U.S. Pat. No. 3,513,073. Pseudomonas fluorescens lipase and methods for its preparation are disclosed in U.S. Pat. No. 3,431,175 and in Clinica Chimica Acta, 81 (1977) 125:130. Both are commercially available and the organisms are on deposit in recognized collections. A unit of lipase activity as used herein is the amount of fatty acid neutralized by one micromole of sodium hydroxide in one minute at 25° C. at pH 8.
The preferred hydrolyzing lipase mixture according to the present invention is an aqueous solution shown in Example 1 below. It is preferably supplied in dry or dried form for stability in storage and is reconstituted with distilled water prior to use.
EXAMPLE 1
______________________________________                                    
Lipase u/ml                                                               
LIPR                ≧250                                           
LPL                 ≧50                                            
Potassium phosphate, mM/l.                                                
                    90                                                    
Bovine serum albumin, g./l.                                               
                    3.8                                                   
pH                  6.5                                                   
______________________________________                                    
For use in a continuous flow instrument such as the Technicon SMAC instrument having a fixed incubation or reaction time of 2.5 minutes at 37° C., a serum sample is diluted 1:6 by volume with distilled water containing a small quantity of surfactant, e.g., 0.1% Triton X-100 (DuPont), and 4.25 parts by volume of the reconstituted lipase reagent is added to each part of diluted sample. 118 ul of diluted sample is used in the above identified instrument and about 0.4 ml of lipase reagent added per test. Complete hydrolysis is obtained in 2.5 minutes.
Comparative tests were run in a continuous flow Technicon instrument with a fixed 2.5 minute reaction time (37° C.) using (1) the aqueous reagent of Example 1 and (2) the standard enzyme mixtures supplied by the Technicon Instrument Corporation comprising a mixture of LIPR and protease as described in U.S. Pat. No. 3,703,591. Good correlation was obtained as illustrated by the typical results shown in Table I below wherein the results given are in mg/dl. triglycerides.
              TABLE I                                                     
______________________________________                                    
Sample      Example 1 Expected Values                                     
______________________________________                                    
1           103       100                                                 
2           269       266                                                 
3           574       --                                                  
4           138       133                                                 
5            90        82                                                 
6           135       131                                                 
7           284       270                                                 
8           577       565                                                 
______________________________________                                    
Samples 1-8 are patient sera where triglyceride concentrations were measured after effecting hydrolysis using the preferred lipase formulation of Example 1 on a Technicon SMAC instrument, and where the Expected Value of each serum was determined using a commercial lipase reagent based on U.S. Pat. No. 3,703,951. Correlation of these sera show that the surfactants used in the instrument calibration did not inhibit the lipase reaction. In each test, glycerol freed by hydrolysis was dialyzed into a flowing stream of assay reagent using the NADH to NAD reactions described above, the resulting change in absorbance being read optically at 340 nm and calibrated to triglyceride concentration in sample.
A preferred free glycerol reagent mixture is given in Example 2 below, the amounts given being per aqueous liter.
EXAMPLE 2
______________________________________                                    
I.    Glycerol Kinase Reagent:                                            
      GK, units           ≧2610                                    
      Triethylamine hydrochloride mM                                      
                          100                                             
II.   Glycerol Substrate Reagent:                                         
      TRIS buffer, mM     32                                              
      Magnesium sulfate, mM                                               
                          8.6                                             
      ATP, mM             8.6                                             
      PEP, mM             .306                                            
      NADH, mM            .273                                            
      LDH, units          ≧2400                                    
      PK, units           ≧1200                                    
______________________________________                                    
These reagents were employed in obtaining the EXAMPLE 1 results reported in TABLE 1. For extended storage, typical ionic and protein stabilizers can be added. Technicon Instrument Corporation commercial reagents were used to obtain the results reported under Expected Values.
Further test have indicated that neither LIPR or LPL alone will fully hydrolyze triglyercides in sample or calibrant within 2.5 minutes incubation time at 37° C. and that the present combination is synergistic. Longer times and temperatures from about room temperature up to about 50° C. may be used, if desired. Sufficient total enzyme within the above ratios should be used to provide full hydrolysis within the time available and the range of concentrations to be assayed.
It should be understood that the foregoing description is for the purpose of illustration and that the present invention includes all equivalents and modifications within the scope of the appended claims.

Claims (9)

What is claimed is:
1. A composition useful for the hydrolysis of a glycerol ester in an aqueous medium comprising a mixture of from about 65 to 91 units of Rhizopus arrhizus lipase and from about 35 to 9 units of Pseudomonas fluorescens lipase per 100 units of total lipase.
2. A composition according to claim 1 wherein the ratio of Rhizopus arrhizus lipase to Pseudomonas fluorescens lipase is between about 2:1 and 10:1.
3. A composition according to claim 2 wherein the ratio is about 5:1.
4. A composition according to claim 1 in an aqueous medium buffered to a pH between about 6.0 and 7.0 and containing at least about 300 units total lipase per milliliter.
5. A dried composition according to claim 4.
6. A reagent composition for determining triglyceride concentration in serum by hydrolyzing triglycerides to glycerol and free fatty acids and measuring the light absorbance of an aqueous fluid containing the hydrolyzed glycerol which comprises an enzyme mixture according to claim 1 together with chemical means for effecting an absorbance change of said aqueous fluid proportional to the amount of glycerol released in the serum.
7. A reagent composition for determining triglyceride concentration in serum by hydrolyzing triglycerides present therein to glycerol and measuring the light absorbance of an aqueous fluid containing said glycerol which comprises a dried enzyme mixture according to claim 5, including chemical means for effecting an absorbance change of said aqueous fluid proportional to the amount of glycerol released in the serum.
8. A reagent composition according to claim 7 wherein said chemical means comprises glycerolkinase, adenosine triphosphate, phosphoenol pyruvic acid, NADH, lactate dehydrogenase and pyruvate kinase.
9. The method for hydrolyzing a glycerol ester and for determining the amount of glycerol ester present in an aqueous body fluid which comprises incubating said fluid with a mixture of enzymes according to claim 1 or 4 for a time less than about ten minutes to fully hydrolyze said glycerol ester and determining the amount of glycerol or fatty acid released by the hydrolysis.
US06/331,449 1979-02-22 1981-12-15 Enzymatic glyceride hydrolysis Expired - Fee Related US4394445A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US06/331,449 US4394445A (en) 1979-02-22 1981-12-15 Enzymatic glyceride hydrolysis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1386279A 1979-02-22 1979-02-22
US06/331,449 US4394445A (en) 1979-02-22 1981-12-15 Enzymatic glyceride hydrolysis

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US1386279A Continuation 1979-02-22 1979-02-22
US06187664 Continuation 1980-09-16

Publications (1)

Publication Number Publication Date
US4394445A true US4394445A (en) 1983-07-19

Family

ID=26685358

Family Applications (1)

Application Number Title Priority Date Filing Date
US06/331,449 Expired - Fee Related US4394445A (en) 1979-02-22 1981-12-15 Enzymatic glyceride hydrolysis

Country Status (1)

Country Link
US (1) US4394445A (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037751A (en) * 1986-01-07 1991-08-06 Gist-Brocades N.V. Microbial purified esterases
US5240851A (en) * 1988-02-22 1993-08-31 Fina Research, S.A. Lipase-producing Pseudomonas aeruginosa strain
US6235480B1 (en) 1998-03-13 2001-05-22 Promega Corporation Detection of nucleic acid hybrids
US6268146B1 (en) 1998-03-13 2001-07-31 Promega Corporation Analytical methods and materials for nucleic acid detection
US6270974B1 (en) 1998-03-13 2001-08-07 Promega Corporation Exogenous nucleic acid detection
US6270973B1 (en) 1998-03-13 2001-08-07 Promega Corporation Multiplex method for nucleic acid detection
US6312902B1 (en) 1998-03-13 2001-11-06 Promega Corporation Nucleic acid detection
US6335162B1 (en) 1998-03-13 2002-01-01 Promega Corporation Nucleic acid detection
US6391551B1 (en) 1998-03-13 2002-05-21 Promega Corporation Detection of nucleic acid hybrids
US6703211B1 (en) 1998-03-13 2004-03-09 Promega Corporation Cellular detection by providing high energy phosphate donor other than ADP to produce ATP
US7067244B2 (en) 2001-04-20 2006-06-27 Chengliang Jiang Rapid triglyceride assay for use in pulp pitch control
US7090975B2 (en) 1998-03-13 2006-08-15 Promega Corporation Pyrophosphorolysis and incorporation of nucleotide method for nucleic acid detection
US20070141692A1 (en) * 2004-08-24 2007-06-21 The Nisshin Oillio Group, Ltd. Lipase powder composition and a process for preparing an esterified compound by using the same
US8268305B1 (en) 2011-09-23 2012-09-18 Bio-Cat, Inc. Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3431175A (en) * 1964-07-18 1969-03-04 Amano Pharma Co Ltd Method for the preparation of a lipoprotein lipase by cultivating organisms
US3513073A (en) * 1968-07-01 1970-05-19 Roland Yves Mauvernay Novel lipase composition and method for producing same
US3703591A (en) * 1970-12-16 1972-11-21 Calbiochem Triglyceride hydrolysis and assay
US3759793A (en) * 1970-01-02 1973-09-18 Boehringer Mannheim Gmbh Process for the quantitative determination of tri di and monoglycerides
US3862009A (en) * 1972-06-19 1975-01-21 Boehringer Mannheim Gmbh Determination of triglycerides
GB1441642A (en) * 1972-12-25 1976-07-07 Ono Pharmaceutical Co Process for the determination of triglyceride in blood serum or tissue
US4056442A (en) * 1976-06-01 1977-11-01 The Dow Chemical Company Lipase composition for glycerol ester determination
US4066508A (en) * 1975-08-12 1978-01-03 Boehringer Mannheim Gmbh Process and reagent for determining triglycerides
US4168203A (en) * 1974-04-30 1979-09-18 Fujisawa Pharmaceutical Co., Ltd. Quantitative analysis of neutral lipids and lecithin

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3431175A (en) * 1964-07-18 1969-03-04 Amano Pharma Co Ltd Method for the preparation of a lipoprotein lipase by cultivating organisms
US3513073A (en) * 1968-07-01 1970-05-19 Roland Yves Mauvernay Novel lipase composition and method for producing same
US3759793A (en) * 1970-01-02 1973-09-18 Boehringer Mannheim Gmbh Process for the quantitative determination of tri di and monoglycerides
US3703591A (en) * 1970-12-16 1972-11-21 Calbiochem Triglyceride hydrolysis and assay
US3862009A (en) * 1972-06-19 1975-01-21 Boehringer Mannheim Gmbh Determination of triglycerides
GB1441642A (en) * 1972-12-25 1976-07-07 Ono Pharmaceutical Co Process for the determination of triglyceride in blood serum or tissue
US4168203A (en) * 1974-04-30 1979-09-18 Fujisawa Pharmaceutical Co., Ltd. Quantitative analysis of neutral lipids and lecithin
US4066508A (en) * 1975-08-12 1978-01-03 Boehringer Mannheim Gmbh Process and reagent for determining triglycerides
US4056442A (en) * 1976-06-01 1977-11-01 The Dow Chemical Company Lipase composition for glycerol ester determination

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"Technicon Method No. SG4-0023PC6," 3/76, Technicon Instruments Corp. *

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037751A (en) * 1986-01-07 1991-08-06 Gist-Brocades N.V. Microbial purified esterases
US5240851A (en) * 1988-02-22 1993-08-31 Fina Research, S.A. Lipase-producing Pseudomonas aeruginosa strain
US6653078B2 (en) 1998-03-13 2003-11-25 Promega Corporation Multiplex method for nucleic acid detection
US6703211B1 (en) 1998-03-13 2004-03-09 Promega Corporation Cellular detection by providing high energy phosphate donor other than ADP to produce ATP
US6270974B1 (en) 1998-03-13 2001-08-07 Promega Corporation Exogenous nucleic acid detection
US6270973B1 (en) 1998-03-13 2001-08-07 Promega Corporation Multiplex method for nucleic acid detection
US6312902B1 (en) 1998-03-13 2001-11-06 Promega Corporation Nucleic acid detection
US6335162B1 (en) 1998-03-13 2002-01-01 Promega Corporation Nucleic acid detection
US6379898B2 (en) 1998-03-13 2002-04-30 John W. Shultz Nucleic acid detection
US6391551B1 (en) 1998-03-13 2002-05-21 Promega Corporation Detection of nucleic acid hybrids
US6235480B1 (en) 1998-03-13 2001-05-22 Promega Corporation Detection of nucleic acid hybrids
US6268146B1 (en) 1998-03-13 2001-07-31 Promega Corporation Analytical methods and materials for nucleic acid detection
US6730479B2 (en) 1998-03-13 2004-05-04 Promega Corporation Detection of nucleic acid hybrids
US20050214753A1 (en) * 1998-03-13 2005-09-29 Promega Corporation Detection of nucleic acid hybrids
US7090975B2 (en) 1998-03-13 2006-08-15 Promega Corporation Pyrophosphorolysis and incorporation of nucleotide method for nucleic acid detection
US20060160166A1 (en) * 2001-04-20 2006-07-20 Enzymatic Deinking Technologies, Llc Rapid triglyceride assay for use in pulp pitch control
US7067244B2 (en) 2001-04-20 2006-06-27 Chengliang Jiang Rapid triglyceride assay for use in pulp pitch control
US20070141692A1 (en) * 2004-08-24 2007-06-21 The Nisshin Oillio Group, Ltd. Lipase powder composition and a process for preparing an esterified compound by using the same
US7811802B2 (en) 2004-08-24 2010-10-12 The Nisshin Oillio Group, Ltd. Lipase powder composition and a process for preparing an esterified compound by using the same
US8268305B1 (en) 2011-09-23 2012-09-18 Bio-Cat, Inc. Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
US9555083B2 (en) 2011-09-23 2017-01-31 Bio-Cat, Inc. Methods and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase

Similar Documents

Publication Publication Date Title
US4259440A (en) Hydrolysis and assay of triglycerides
Werner et al. Ultramicro determination of serum triglycerides by bioluminescent assay.
US4543326A (en) Stabilization of oxidase
US4394445A (en) Enzymatic glyceride hydrolysis
US4056442A (en) Lipase composition for glycerol ester determination
US3759793A (en) Process for the quantitative determination of tri di and monoglycerides
CA1125151A (en) Triglycerides assay and reagents therefor
ES2372859T3 (en) COMPOSITIONS FOR THE DETERMINATION OF THE ACTIVITY LIPASA AND METHOD FOR DETERMINING THE ACTIVITY.
CA1054907A (en) Method and composition for blood serum cholesterol analysis
US3862009A (en) Determination of triglycerides
Mizuno et al. A new enzymatic method for colorimetric determination of free fatty acids
CA1148456A (en) Process and reagent for determining triglycerides
GB2115926A (en) Method for the quantitative determination of physiological components in biological fluids
JPH0254079B2 (en)
US5232846A (en) Method for producing a thermostable lipoprotein lipase from streptomyces
US4223090A (en) Reagents for the enzymatic determination of triglycerides
CS219875B2 (en) Method of fixing the triglycerine
Fossati et al. Kinetic colorimetric assay of lipase in serum
US4045297A (en) Triglycerides determination method
US4022667A (en) Substrate solution for carboxylic ester hydrolase determination
US5244798A (en) Reagent for determining triglycerides comprising a thermostable lipoprotein lipase from streptomyces
US4596772A (en) Reagent for assaying cholinesterase
DE3006789A1 (en) METHOD AND ENZYME COMPOSITION FOR THE HYDROLYSIS OF GLYCERINE ESTERS
EP0045032B1 (en) A triglyceride analysis composition and a method for triglyceride determination
US4151043A (en) Enzyme determination method

Legal Events

Date Code Title Description
AS Assignment

Owner name: COOPERBIOMEDICAL, INC., 3145 PORTER DRIVE, PALO AL

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:FLOW GENERAL INC., A DE CORP;REEL/FRAME:004286/0086

Effective date: 19840307

FEPP Fee payment procedure

Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 19870719